From a leading futurist and OneShared.World founder, a brilliant book that explores how artificial intelligence and other revolutionary technologies are transforming our lives-and our future (Sanjay Gupta MD, bestselling author, neurosurgeon, and Emmy-award winning chief medical correspondent (CNN)

New technologies have the potential to improve our health, feed billions of people, supercharge our economies, store essential information for millions of years, and save our planet. But if we're not careful, they can also do immeasurable harm. Luckily, in Jamie Metzl, we have a leading expert who integrates science, technology, history, politics, and international affairs to envision a future that most specialists, almost by definition, cannot see.

In this bold and inspiring exploration of transformative human knowledge, Metzl gives us the definitive account of the technological precipice on which we stand and the map to where we go from here.

RFK Jr. exposes the decades of lies.--Luc Montagnier, Nobel laureate

From the New York Times, Wall Street Journal, USA Today, and Publishers Weekly bestselling author of The Real Anthony Fauci comes an explosive exposé of the cover-up behind the true origins of COVID-19.

Gain-of-function experiments are often conducted to deliberately develop highly virulent, easily transmissible pathogens for the stated purpose of developing preemptive vaccines for animal viruses before they jump to humans. More insidious is the dual use nature of this research, specifically directed toward bioweapons development.

The Wuhan Cover-Up pulls back the curtain on how the US government's increase in biosecurity spending after the 2001 terror attacks set in motion a plan to transform the National Institute of Allergy and Infectious Diseases (NIAID), under the direction of Dr. Anthony Fauci, into a de facto Defense Department agency.

While Dr. Fauci zealously funded and pursued gain-of-function research, concern grew among some scientists and government officials about the potential for accidental or deliberate release of weaponized viruses from labs that might trigger worldwide pandemics. A moratorium was placed on this research, but true to form, Dr. Fauci found ways to continue unperturbed--outsourcing some of the most controversial experiments offshore to China and providing federal funding to Wuhan Institute of Virology's (WIV's) leading researchers for gain-of-function studies in partnership with the Chinese military and the Chinese Communist Party.

Robert F. Kennedy Jr.'s meticulously researched and rigorously sourced analysis leads readers on a staggering journey to learn about:

• the key enablers and henchmen pushing for gain-of-function research
• the economic motives behind gain-of-function research
• successfully engineered chimeric viruses that can infect and kill humans
• the coordinated effort to silence speculation of COVID-19's laboratory genesis
• the complicity of scientific journals to hide the origins of COVID-19
• the role of the Wuhan Institute of Virology in China's biowarfare/biodefense program
• the relationships between US health, military, and intelligence bureaucracies and scientists and their Chinese counterparts
• the roles of Bill Gates and Sir Jeremy Farrar in orchestrating a global cover-up

The Wuhan Cover-Up unveils a global conspiracy of epic proportion and lethal consequence.

In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history. Coming at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise. Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company, depicting Genentech's improbable creation, precarious youth, and ascent to immense prosperity. Hughes provides intimate portraits of the people significant to Genentech's science and business, including cofounders Herbert Boyer and Robert Swanson, and in doing so sheds new light on how personality affects the growth of science. By placing Genentech's founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits. Integrating the scientific, the corporate, the contextual, and the personal, Genentech tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it.

An insider's view on bringing extinct species back to life

Could extinct species, like mammoths and passenger pigeons, be brought back to life? In How to Clone a Mammoth, Beth Shapiro, an evolutionary biologist and pioneer in ancient DNA research, addresses this intriguing question by walking readers through the astonishing and controversial process of de-extinction. From deciding which species should be restored to anticipating how revived populations might be overseen in the wild, Shapiro vividly explores the extraordinary cutting-edge science that is being used to resurrect the past. Considering de-extinction's practical benefits and ethical challenges, Shapiro argues that the overarching goal should be the revitalization and stabilization of contemporary ecosystems. Looking at the very real and compelling science behind an idea once seen as science fiction, How to Clone a Mammoth demonstrates how de-extinction will redefine conservation's future.

A Harvard biologist and master inventor explores how new biotechnologies will enable us to bring species back from the dead, unlock vast supplies of renewable energy, and extend human life.

In Regenesis, George Church and science writer Ed Regis explore the possibilities of the emerging field of synthetic biology. Synthetic biology, in which living organisms are selectively altered by modifying substantial portions of their genomes, allows for the creation of entirely new species of organisms. These technologies-far from the out-of-control nightmare depicted in science fiction-have the power to improve human and animal health, increase our intelligence, enhance our memory, and even extend our life span. A breathtaking look at the potential of this world-changing technology, Regenesis is nothing less than a guide to the future of life.

This book goes through the most common food fears and myths and debunk them with some simple science. Told in readable story form, the book tackles HFCS, MSG, food colorings, raw milk, organic farming, GMOs and biotechnology, sugars, artificial sweeteners and honey. Every chapter ends with footnotes to actual papers that help reassure you that we have one of the safest food systems in the world.

A lively and endlessly fascinating deep-dive into nature and the many groundbreaking human inventions inspired by the wild.

Delightful.--The Guardian

Fans of Helen Scales won't want to miss this.--Publishers Weekly STARRED Review

When astronomers wanted a telescope that could capture X-rays from celestial bodies, they looked to the lobster. When doctors wanted a medication that could stabilize Type II diabetic patients, they found their muse in a lizard. When scientists wanted to drastically reduce emissions in cement manufacturing, they observed how corals construct their skeletons in the sea. This is biomimicry in action: taking inspiration from nature to tackle human challenges.

In Nature's Wild Ideas, Kristy Hamilton goes behind the scenes of some of our most unexpected innovations. She traverses frozen waterfalls, treks through cloudy forests, discovers nests in the Mojave desert, scours intertidal zones and takes us to the deepest oceans and near volcanoes to introduce us to the animals and plants that have inspired everything from cargo routing systems to non-toxic glues, and the men and women who followed that first spark of I wonder all the way to its conclusion, sometimes against all odds.

While the joy of scientific discovery is front and center, Nature's Wild Ideas is also a love letter to nature--complete with a deep message of conservation: If we are to continue learning from the creatures around us, we must protect their untamed homelands.

This book is written, keeping the undergraduate students in mind, with the aim to develop foundation of the novice in the field of biotechnology. The book is written in simple and easy to understand language. The various fundamental concepts involved are explained lucidly with vivid diagrams and suitable illustrations.

This book deals with genetics and genetic engineering principles with applications in pharmaceutical biotechnology; fermentation process; plant cell/tissue culture and animal cell/tissue/organ culture; hybridoma technology and novel methods for the production of monoclonal antibodies; transformative capacity of microbes in production of hard to synthesize pharmaceuticals; methods of cell immobilization and their applications; environmental and social role of biotechnology; and bioinformatics.

Welcome to the biotech revolution
In the last century, technology has transformed the human experience across the world. This has been super-charged by the arrival of the internet, smart phones, AI and machine learning, and created trillion-plus dollar companies and household names like Apple, Amazon, Google and Microsoft.

Our Future is Biotech explains why biotech is next: because our biggest remaining challenges as a species concern biological systems. Biotech companies will solve our most intractable problems, from cancer, dementia, obesity and diabetes to elderly care, mental health conditions, and even power generation, agricultural production and environmental degradation.

Biotech means that we will live better, safer, healthier, wealthier, happier, and longer lives. The industry has already delivered miracle cures for several diseases, and there is more to come. But despite this, few people are aware of the phenomenal progress being made. Our Future is Biotech addresses this, explaining what biotech is, what is coming next, and how you might profit from it too. Tech has been the most important theme for human progress for the last century. Biotech is next.

AAM: Fungal Stress Mechanisms and Responses explores the adaptive strategies and biotechnological applications of fungi under stress conditions. This volume features an array of reviews by experts in the field, reviewing different aspects of fungal stress responses. The initial three chapters focus on stress in fungal insect pathogens, while chapters 4-6 address the impact of stressful environmental conditions on fungi used for bioremediation. The last chapter investigates the molecular aspects of copper homeostasis in human fungal pathogens. This volume offers a comprehensive collection of findings that help our understanding of fungal stress responses and their applications in agriculture, medicine, and the environment.

From the contributors to The Conversation, this collection of essays by leading experts in biotechnology provides foundational knowledge on a range of topics, from CRISPR gene sequencing to the ethics of GMOs and designer babies.

In The Conversation on Biotechnology, editor Marc Zimmer collects essays from The Conversation U.S. by top scholars and experts in the field, who present a primer on the latest biotechnology research, the overwhelming possibilities it offers, and the risks of its abuse. From an overview of CRISPR technology and gene editing in GMOs to the ethical questions surrounding designer babies and other applications of biotechnology in humans, it highlights the major implications biotechnology will bring for health and society. Topics range from the spectacular use of light to fire individual neurons in the brain to making plant-based meats; from curbing diseases with genetically modified mosquitoes to looking back on 40 years of opinions on IVF babies.

The Critical Conversations series collects essays from top scholars on timely topics, including water, biotechnology, gender diversity, gun culture, and more, originally published on the independent news site The Conversation U.S.

Contributors: Nathan Ahlgren, Ivan Anishchenko, Trine Antonsen, Jennifer Barfield, Pedro Belda-Ferre, Ari Berkowitz, Adeline Boettcher, Jason Delbourne, Kevin Doxzen, Mo Ebrahimkhani, Eleanor Feingold, J. Benjamin Hurlbut, Cecile Janssens, Samira Kiani, Amanda Kowalczyk, Mariana Lamas, Andrew Lapworth, Rebecca Mackelprang, Kathleen Merrigan, Saman Naghieh, Sean Nee, Dimitri Perrin, Christopher Preston, Jason Rasgon, Penny Riggs, Jason Robert, Oliver Rogoyski, Gary Samore, Sahotra Sarkar, George E. Seidel, Patricia A. Stapleton, Craig W. Stevens, Paul B. Thompson, Christopher Tuggle, Vikramaditya G. Yadav, Marc Zimmer

A century ago, discoveries in physics came together with engineering to produce an array of astonishing new technologies that radically reshaped the world: radios, televisions, aircraft, computers, and a host of still-evolving digital tools. Today, a new technological convergence--of biology and engineering--promises to create the tools necessary to tackle the threats we now face, including climate change, drought, famine, and disease

World-renowned neuroscientist and academic leader Susan Hockfield describes the most exciting new developments and the scientists and engineers who helped to create them. Virus-built batteries. Cancer-detecting nanoparticles. Computer-engineered crops. Together, they highlight the promise of the technology revolution of the twenty-first century to overcome some of the greatest humanitarian, medical, and environmental challenges of our time.

Throughout history, humankind has pursued means to improve the yield of crop plants through selective plant breeding and hybridization. Today, genetic manipulation provides a powerful tool for directing plant breeding. But how is genetic manipulation implemented? What benefits can it offer? And what are the broader issues surrounding the use of this technology?

The second edition of Plant Biotechnology: The Genetic Manipulation of Crop Plants presents a balanced, objective exploration of the technology behind genetic manipulation, and the application of this technology to the growth and cultivation of plants. The book describes the techniques underpinning genetic manipulation in a clear, lucid manner, and this influential tool is used in practice.

Estás a punto de descubrirlo! Abre este libro y explora el asombroso mundo de la biología: la ciencia que estudia a los seres vivos, desde las enormes ballenas azules hasta las microscópicas bacterias que viven en tu piel.

This book provides an excellent platform for understanding the chemical processes involved in food transformation. Starting with the examination of major food components, such as water, carbohydrates, lipids, proteins and minerals, the author further introduces the biochemistry of digestion and energy metabolism of food ingredients. The last section of the book is devoted to modern food technologies and their future perspectives.

Prozesse, die für die Marktreife von Medikamenten erforderlich sind. Behandelt werden unter anderem vorklinische Studien, klinische Studien am Menschen, regulatorische Kontrollen und sogar die Herstellungsprozesse von pharmazeutischen Produkten. Nach einen prägnanten und leicht verständlichen Vorstellung der grundlegenden Konzepte werden die Zielstrukturen und der Entwicklungsprozess von klein- und gro molekularen Arzneimittel präsentiert. In der 3. aktualisiertenAuflage ist dieses Fachbuch noch ansprechender. Neben den neuesten Entwicklungen werden die einzelnen Themen noch umfassender erläutert und durch zusätzliche Materialien und Fallstudien für den Einsatz an Hochschulen und Universitäten ergänzt. Die Biotechnologie ist ein dynamisches Fachgebiet. Forschung und Entwicklung, klinische Prüfungen, Herstellungsverfahren und regulatorische Prozesse unterliegen ständigen Veränderungen. Biotechnologie und Biowissenschaften sind vom globalem Interesse. Daher besetzt dieses Fachbuch eine Nische und erhält immer wieder gute Kritiken. Die überarbeitete 3. Auflage sorgt für anhaltende Relevanz und Nutzen für die Leser.

What happens when migration takes place between sites defined by different types of 'colonial difference'? This book asks this question in the context of Somali migration to Scotland, which it maps over a century of colonial relations, independence movements, and the reorganisation of the (post)colonial Somali and British states. Framing both Somalia and Scotland as sites of marginality in the matrices of colonial power, it tracks through a combination of archival material and contemporary testimonies the operation, development and divergence of (the) colonial(ity of) power in shaping Somali migration and citizenship experiences in Scotland. However, whilst the book has a grounded and localised focus, it makes the argument that Somali-Scottish migration cases present the urgent need for a holistic approach to the operation of coloniality, which not only emanates from the so-called 'centre' of Empire, but also at and between its edges.

Stephen Heywood was twenty-nine years old when he learned that he was dying of ALS -- Lou Gehrig's disease. Almost overnight his older brother, Jamie, turned himself into a genetic engineer in a quixotic race to cure the incurable. His Brother's Keeper is a powerful account of their story, as they travel together to the edge of medicine.

The book brings home for all of us the hopes and fears of the new biology. In this dramatic and suspenseful narrative, Jonathan Weiner gives us a remarkable portrait of science and medicine today. We learn about gene therapy, stem cells, brain vaccines, and other novel treatments for such nerve-death diseases as ALS, Alzheimer's, and Parkinson's -- diseases that afflict millions, and touch the lives of many more.

The Heywoods' story taught me many things about the nature of healing in the new millennium, Weiner writes. They also taught me about what has not changed since the time of the ancients and may never change as long as there are human beings -- about what Lucretius calls 'the ever-living wound of love.'

This P.S. edition features an extra 16 pages of insights into the book, including author interviews, recommended reading, and more.

Why has the biotechnology industry failed to perform up to expectations--despite all its promise? In Science Business, Gary P. Pisano answers this question by providing an incisive critique of the industry. Pisano not only reveals the underlying causes of biotech's problems; he offers the most sophisticated analysis yet on how the industry works. And he provides clear prescriptions for companies, investors, and policy makers seeking ways to improve the industry's performance. According to Pisano, the biotech industry's problems stem from its special character as a science-based business. This character poses three unique business challenges: how to finance highly risky investments under profound uncertainty and long time horizons for R&D, how to learn rapidly enough to keep pace with advances in drug science knowledge, and how to integrate capabilities across a broad spectrum of scientific and technological knowledge bases.The key to fixing the industry? Business models, organisational structures, and financing arrangements that place greater emphasis on integration and long-term learning over shorter--term 'monetisation' of intellectual property. Pisano maintains that all industry players--biotech firms, investors, universities, pharmaceutical companies, government regulators--can play a role in righting the industry. The payoff? Valuable improvements in health care, and a shinier future for human well-being.

In this timely and controversial work, Sue Hubbell contends that the concept of genetic engineering is anything but new, for humans have been tinkering with genetics for centuries. Focusing on four specific examples -- corn, silkworms, domestic cats, and apples -- she traces the histories of species that have been fundamentally altered over the centuries by the whims and needs of people.